Literature DB >> 11984473

[MRI: an essential examen for the management of sacrococcygeal chondromas].

H Brunel1, P Peretti-Viton, V Benguigui-Charmeau, F Borrione, P Roche, L Do, C Raybaud.   

Abstract

Chordomas are rare tumors, involving mainly the sacrococcygeal area and the clivus. Although a significant radiological semiology exists (osteolytic, lobulated, calcified tumor), the definite diagnosis is histological. Five cases of sacral and/or coccygeal chordomas were studied by CT scan and MRI. Clinical, radiological (tumoral topography and extension) and histological data were noted in all cases. At CT scan, the tumor was median, osteolytic, often calcified, of intermediate density, sparing iliac bones. MRI showed, in all the cases, a tumoral lobulation making easier the diagnosis of chordoma. Futhermore, as compared to CT scan MRI brought new information for the study of the tumoral extension, revealing a frequent involvement of adjacent muscles and spinal canal. It also showed that the tumor most often spared the rectal wall. These data are fundamental in the management of patients: the therapeutical aim must be, if possible, a complete removal of the tumor. Thus, besides its interest in the diagnosis, MRI appears to be essential in the pre-therapeutical assessment of sacro-coccygeal chordomas.

Entities:  

Mesh:

Year:  2002        PMID: 11984473

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  3 in total

1.  [Imaging of sacral chordoma: comparison between MRI and CT].

Authors:  C Plathow; M-A Weber; J Debus; H-U Kauczor
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

2.  Two Cases of Dedifferentiated Chordoma in the Sacrum.

Authors:  Seon Chun Kim; Wonik Cho; Ung-Kyu Chang; Sang Min Youn
Journal:  Korean J Spine       Date:  2015-09-30

3.  [Sacrococcygeal chordoma: about a case].

Authors:  Mohamed Moukhlissi; Ahmed Ben Sghier; Mohammed Bensaid; Loubna Mezouar
Journal:  Pan Afr Med J       Date:  2021-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.